The drug from Merck was OK’d for patients with artery-clogging cholesterol that persists even after taking statins.
Shares of American Superconductor Corporation (AMSC 6.26%) rallied 44.2% in the first half of 2026, according to data from ...
The Food and Drug Administration approved a first-of-its-kind pill that can reduce cholesterol in a way that’s previously ...
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only ...
Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sacituzumab tirumotecan (sac-TMT), ...
Clinical trials show targeted kinase inhibitors provide high response rates in children with refractory histiocytic disorders ...
Crisis pregnancy centers said they are seeing more requests to reverse the effects of abortion pills and are expanding access ...
Copyright: Crown Copyright © 2025 Published by Elsevier Ltd. 14 manufacturers took part in the study, submitting results from 22 different test and target ...
At the beginning of the year, the National Fire Protection Association’s (NFPA) new Standard for the Installation of Stationary Energy Storage Systems (NFPA 855) went into effect. The updated NFPA 855 ...
A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient's heart ...
A novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronary artery are restricting blood flow to the patient’s heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results